SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K/A - Current report: [Amend]
SEC Accession No. 0001193125-22-290076
Filing Date
2022-11-21
Accepted
2022-11-21 17:27:17
Documents
16
Period of Report
2022-11-01
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K/A d418015d8ka.htm   iXBRL 8-K/A 32834
2 EX-99.1 d418015dex991.htm EX-99.1 288156
3 EX-99.2 d418015dex992.htm EX-99.2 183706
4 EX-99.3 d418015dex993.htm EX-99.3 162267
  Complete submission text file 0001193125-22-290076.txt   934741

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA ignyu-20221101.xsd EX-101.SCH 4247
6 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE ignyu-20221101_def.xml EX-101.DEF 14720
7 XBRL TAXONOMY EXTENSION LABEL LINKBASE ignyu-20221101_lab.xml EX-101.LAB 24769
8 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE ignyu-20221101_pre.xml EX-101.PRE 15819
10 EXTRACTED XBRL INSTANCE DOCUMENT d418015d8ka_htm.xml XML 7419
Mailing Address 3350 W BAYSHORE RD. SUITE 100 PALO ALTO CA 94303
Business Address 3350 W BAYSHORE RD. SUITE 100 PALO ALTO CA 94303 (650) 549-9103
Peak Bio, Inc. (Filer) CIK: 0001834645 (see all company filings)

IRS No.: 852448157 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K/A | Act: 34 | File No.: 001-39951 | Film No.: 221406808
SIC: 2836 Biological Products, (No Diagnostic Substances)